BostonGene’s mission is to power healthcare’s transition to personalized medicine using AI-based molecular and immune profiling to improve the standard of care, accelerate research, and improve economics. The BostonGene Tumor PortraitTM Test reveals key drivers of each tumor, including immune microenvironment properties, actionable mutations, biomarkers of response to diverse therapies, and recommended therapies. Through these comprehensive analyses, the BostonGene Tumor PortraitTM Test generates a personalized roadmap for therapeutic decision-making for each cancer patient.
Additional Info
Will your company display a new product or promote a new indication/enhanced feature(s) for an existing product in your booth?
Yes